Evidence map›Paper›PMID 34990874›Full record

ArticleAmerican journal of obstetrics & gynecology MFM2022

Clinical factors associated with cytomegalovirus shedding among seropositive pregnant women.

Luke A Gatta, Eric Rochat, Jeremy M Weber, Sarah Valencia, Alaattin Erkanli, Sarah K Dotters-Katz, Sallie Permar, Brenna L Hughes

Open access · greenAbstract read
In one paragraph

Article in American journal of obstetrics & gynecology MFM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Luke A GattaDepartment of Obstetrics and Gynecology, Duke University Hospital, Durham, NC (Drs Gatta, Dotters-Katz, and Hughes); Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Duke University Hospital, Durham, NC (Drs Gatta, Dotters-Katz, and Hughes). Electronic address: luke.gatta@duke.edu.
Eric RochatDuke Human Vaccine Institute, Duke University Hospital, Durham, NC (Mr Rochat and Drs Valencia and Permar).
Jeremy M WeberDepartment of Biostatistics and Bioinformatics, Duke University Hospital, Durham, NC (Mr Weber and Dr Erkanli).
Sarah ValenciaDuke Human Vaccine Institute, Duke University Hospital, Durham, NC (Mr Rochat and Drs Valencia and Permar).
Alaattin ErkanliDepartment of Biostatistics and Bioinformatics, Duke University Hospital, Durham, NC (Mr Weber and Dr Erkanli).
Sarah K Dotters-KatzDepartment of Obstetrics and Gynecology, Duke University Hospital, Durham, NC (Drs Gatta, Dotters-Katz, and Hughes); Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Duke University Hospital, Durham, NC (Drs Gatta, Dotters-Katz, and Hughes).
Sallie PermarDuke Human Vaccine Institute, Duke University Hospital, Durham, NC (Mr Rochat and Drs Valencia and Permar); Department of Pediatrics, Weill Cornell Medical Center, New York, NY (Dr Permar).
Brenna L HughesDepartment of Obstetrics and Gynecology, Duke University Hospital, Durham, NC (Drs Gatta, Dotters-Katz, and Hughes); Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Duke University Hospital, Durham, NC (Drs Gatta, Dotters-Katz, and Hughes).
Duke University Hospital · USCornell University · US

Funding

Clinical and viral characteristics of maternal cytomegalovirus infection among seropositive pregnant women in the United StatesR21HD096867 · NICHD · DUKE UNIVERSITY · PI HUGHES, BRENNA L. · 2018 to 2019
$442k
NICHD NIH HHS R21 HD096867
6 · The paper itself

Abstract

backgroundBoth neighborhood disadvantage and close contact with children have been associated with seroprevalence of cytomegalovirus in pregnancy. However, it is unknown which individual factors influence whether seropositive women are likely to have ongoing viral shedding.

objectiveThis study aimed to define the frequency of and risk factors for ongoing maternal cytomegalovirus shedding across gestation among seropositive pregnant women. STUDY

designThis was a prospective cohort study of women who were cytomegalovirus seropositive at a single tertiary care hospital between September 1, 2018, and September 1, 2020. The participants were eligible if positive for cytomegalovirus immunoglobulin G during the first trimester of pregnancy. Urine samples were planned to be collected from each trimester. DNA was isolated in urine samples to detect and quantitate cytomegalovirus immediate-early 1 gene. Participants were classified as "ever shedder" if cytomegalovirus was detected in any urine sample and "never shedder" if cytomegalovirus was never detected. Patient demographics and characteristics were compared between groups. Stochastic search variable selection (with a posterior probability of inclusion of >0.5) was used to identify predictors of cytomegalovirus shedding at any time point. Forward selection modeling was used as a sensitivity check for independent risks.

resultsA total of 240 participants who were cytomegalovirus immunoglobulin G seropositive were enrolled, with 567 urine samples analyzed across gestation. Fifty-eight participants (24.2%) were "never shedders", and 182 participants (75.8%) were "ever shedders." The characteristics and demographics were similar between cohorts. With stochastic search variable selection, nulliparity was the only variable selected (odds ratio, 1.82; 95% credible interval, 1.00-4.09; Bayes factor, 2.22). Furthermore, nulliparity was selected with standard logistic regression, with an odds ratio and 95% confidence interval of 1.89 (1.00-3.58). Sociodemographic characteristics, such as age, race, education level, occupation, children at home, children in daycare, housing type, insurance type, income, and concurrent infections, were not associated with shedding. The only positive neonatal sample (0.42%) was detected from a participant who had cytomegalovirus detected in all 3 time points.

conclusionApproximately 75% of women who were positive for cytomegalovirus immunoglobulin G shed virus at some point during gestation. Nulliparity was the only variable selected that was associated with shedding.

Indexed as

CytomegalovirusCytomegalovirus InfectionsAntibodies, ViralBayes TheoremChildFemaleHumansImmunoglobulin GInfant, NewbornPregnancyPregnant PeopleProspective StudiesSeroepidemiologic StudiesAntibodies, ViralImmunoglobulin Gantiviral agentscongenital cytomegaloviruscongenital viral infectioncytomegaloviruscytomegalovirus immunoglobulin Gfetal infectionsecondary maternal cytomegalovirus infectionseroconversion

Identifiers

PMID34990874
PMCPMC9942897
OpenAlexW4205245946

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.